The Weekly Roundup: May 16-20

ICYMI, this week we had stories from the 2022 American College of Mohs Surgery Annual Meeting, bimekizumab's FDA set back, and more.

POLL: What Type of Content Would You Like to See More Of?

Improvement Needed in Immediate Access to VA Skin Cancer Care in Midwest, East Coast

In a presentation at the current American College of Mohs Surgery meeting, Jennifer G. Powers, MD, highlights the needed improvement for immediate access to skin cancer care for VA patients, noting a 33 day average wait time compared to the VAs optimal goal of 28 days.

Seconds Matter: A Pearl for Improving Communication During Surgery

Presenters highlight the possible solutions to communication between the scrubbed-in surgery team and outside help that could save time.

Examining These Patient Variables May Help Predict Aggressive Basal Cell Carcinomas

A study presented at the current ACMS meeting highlights variables that could predict BCC, including: gender, immune status, and more.

Carefully Consider Post-Op Bleeding Risk when Treating Patients with Chronic Lymphocytic Leukemia

At the current ACMS meeting, Kelsey E. Hirotsu, MD, discussed the bleeding complications seen in patients on ibrutinib for CLL.

What’s Ahead for Melanoma Management

Immunotherapy, intralesional treatments, multidisciplinary care teams define rapidly-evolving multimodal approach.

Hope for the Future: Innovative Physicians Changing the Way Health Care Delivered

Marty Makary, MD, MPH, predicts systemwide change in the world of health care.

Periosteal Flap Safety, Effectiveness, and Aesthetic Quality in Posterior Lamella Reconstruction

Single-stage periosteal flap technique to treat full-thickness eyelid defects is safe, effective, and aesthetically acceptable, according to a study presented at the 2022 American College of Mohs Surgery Annual Meeting on May 12, 2022.

Topical Tranexamic Acid Shows Efficacy for Postoperative Bleeding Reduction

Topical tranexamic acid is an effective wound care adjunct in reducing rates of postoperative bleeding of granulating defects in Mohs micrographic surgical settings.

Chart the Changes in NMSC Prevalence and Procedural Treatments

Overall, non-melanoma skin cancer (NMSC) visits (all pooled specialties/areas) have been plateauing. However , metropolitan but not rural areas saw an increase in visits where NMSC was the chief complaint. However, the percentage of NMSC in rural areas that is managed by dermatologists and dermatologic surgeons is also on the rise, according to a presentation given at the 2022 American College of Mohs Surgery Annual Meeting.

How to Ensure Outdoor Workers Use Sun Protection

Sunscreen use is on the rise, but further education is needed.

Staging Accuracy for Squamous Cell Carcinoma

At the ACMS meeting, Chrysalyne D. Schmults, MD, MScE, highlighted molecular diagnostics for squamous cell carcinoma.

Bimekizumab Fails FDA Pre-Approval Inspection

UCB announced the FDA issued a CRL that stated that the FDA cannot approve the BLA in its current form.

Multiple Myeloma May Increase Incidence of Melanoma

A poster presented at the 2022 American College of Mohs Surgery Annual Meeting not only suggested a link between multiple myeloma and a heightened rate of melanoma, but also demonstrated potential for higher overall mortality rates.

Sunscreen Education Needed for All Ages

Data from one study showed younger women more likely to use sunscreen than older adults.

Access to Mohs Surgeon a Barrier to Referral

A survey asked dermatologists whether they had personal treated head and neck melanoma with excision, and if and when they referred patients with melanoma on the head and neck to a Mohs surgeon.

Majority of patients OK with artificial intelligence helping with diagnosis or treatment options

Many patients worry about privacy and accuracy.

Many older adults can’t afford prescription drug insurance

Lower household income and requiring multiple medications play large roles.

The Cutaneous Connection: Adherence to Atopic Dermatitis Treatment

In this episode, the topics up for discussion include possible technologies to help atopic dermatitis patient adherence with treatment along with new strategies to improve patient experiences at the practice.

Refocusing on Venous Thromboembolism and Chronic Inflammatory Skin Diseases

Patients with chronic inflammatory skin diseases do not have an increased risk of venous thromboembolism (VTE) compared to a matched healthy control cohort. This knowledge can be useful to clinicians when contemplating systemic immunomodulatory therapies in their dermatologic patients.

Pointers with Dr Portela: Between Two Derms Podcast

In this week’s Pointers with Dr Portela, the 208SkinDoc hosts a podcast called, “Between Two Derms.” This week he covers cases in the clinic, psoriasis at the Met Gala and more.

Study: Overlapping Comorbidity Risks Found in Psoriasis and Palmoplantar Pustulosis

The risks of certain comorbid conditions varied between the 2 groups of patients.

Study: Lifestyle Behaviors Linked With Psoriasis Development

Lifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.

Sunscreen Protection for Children

Protection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course for your patients and their families on sun protection, which can go a long way in preventing skin damage and disorders due to the sun.

Skin Cancer Foundation Raises $625,000 For Skin Cancer Education Programs

The Skin Cancer Foundation at its Annual Champions for Change Gala in New York, New York, raised the money while also honoring 157 dermatologists for volunteering with the Foundations skin cancer screening program on May 12.

Biosimilars for Humira Are on Their Way

In 2023 as many as 11 biosimilars to Humira are headed for the US market.

Avoiding Abbreviations Boosts Patient Understanding of Health Records

Study shows a marked improvement when medical abbreviations and acronyms are spelled out instead.